Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Tracking America's Recovery
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Merck & Co Inc
(NYSE:MRK)
83.18
Delayed Data
As of Jan 19
-0.20
/
-0.24%
Today’s Change
65.25
Today
|||
52-Week Range
90.97
+1.69%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest MRK News
|
Press Releases
Why Gilead Sciences Stock Is Jumping Today
Jan 19 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Coca-Cola, Merck, Royal Dutch Shell, Gilead Sciences and FedEx
Jan 11 / Zacks.com - Paid Partner Content
Biohaven (BHVN) Falls as Troriluzole Fails in Alzheimer's Study
Jan 19 / Zacks.com - Paid Partner Content
The Top 3 Biotech Stocks to Buy in 2021
Jan 10 / MotleyFool.com - Paid Partner Content
AstraZeneca's (AZN) Enhertu Gets FDA Nod for Gastric Cancer
Jan 19 / Zacks.com - Paid Partner Content
9 Dow Stocks With the Most Upside Potential, According to Wall Street
Jan 10 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Gets EU Nod for Improved Imfinzi Dosing
Jan 18 / Zacks.com - Paid Partner Content
Merck (MRK) Stock Sinks As Market Gains: What You Should Know
Jan 08 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Xalkori Gets FDA Nod for Rare Lymphoma in Kids
Jan 15 / Zacks.com - Paid Partner Content
Top Analyst Reports for Coca-Cola, Merck & Royal Dutch Shell
Jan 08 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals
Jan 15 / Zacks.com - Paid Partner Content
Pfizer (PFE) Begins Dosing in DMD Study With Gene Therapy
Jan 08 / Zacks.com - Paid Partner Content
Merck (MRK) Stock Moves -0.21%: What You Should Know
Jan 14 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: ABBV's Positive Skyrizi Data, AZN, PFE, RHHBY's FDA Updates
Jan 08 / Zacks.com - Paid Partner Content
Esperion (ESPR) Reports Q4 Preliminary Results, Stock Down
Jan 14 / Zacks.com - Paid Partner Content
Corporate America is finally divorcing Trump
Jan 08 / CNN.com - Paid Partner Content
Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA
Jan 13 / Zacks.com - Paid Partner Content
The Dogs of the Dow Didn't Hunt in 2020, and 2021 Isn't Looking Much Better
Jan 07 / MotleyFool.com - Paid Partner Content
3 Coronavirus Stocks to Stay Miles Away From in 2021
Jan 12 / MotleyFool.com - Paid Partner Content
Dow Jones Jumps 600 Points: Bet on 4 Momentum Stocks to Win Big
Jan 07 / Zacks.com - Paid Partner Content
Why 2021 could be the year of the Dow dogs
Jan 12 / CNN.com - Paid Partner Content
2 Value Stocks to Buy With Your $600 Stimulus Check That Can Make You Rich
Jan 07 / MotleyFool.com - Paid Partner Content
Sanofi (SNY) to Acquire Kymab to Boost Immunology Presence
Jan 11 / Zacks.com - Paid Partner Content
Jeff Bezos, Jamie Dimon and Warren Buffett tried to solve health care. 3 years later, their company has shut down
Jan 04 / CNN.com - Paid Partner Content